CHI and Bio-IT World Announce Fragment-Based Drug Design Session at Upcoming Event

April 7, 2011 - PRLog -- Cambridge Healthtech Institute and Bio-IT World is pleased to announce a new session just added to its 11th Annual Structure-Based Drug Design (SBDD) conference.  The session is titled Fragment-Based Drug Design.  The SBDD conference will be held on June 8-10, 2011 at the Royal Sonesta Hotel Boston in Cambridge, Massachusetts.  This meeting serves as the annual forum for the structure-based drug design community, providing insights on the latest development in computational technology for drug discovery, and puts structure-based molecular approaches into the perspective of targeted therapeutics.

The Fragment-Based Drug Design session is scheduled on Thursday, June 9 from 1:30-5:00 p.m.  The following presentations are scheduled during this time:

Practical Concepts in Fragment-to-Lead Optimization
Marcel Verdonk, Ph.D., Director, Computational Chemistry and Informatics, Astex Therapeutics Ltd.

Making Decisions in Fragment-Based Discovery
Roderick Hubbard, Ph.D., Professor, University of York and Director, Stuctural Sciences, Vernalis Ltd.

Applying Integral Equation Theory to Structure Based Design
Jean-François Truchon, Ph.D., Research Scientist, Chemical Computing Group

A Computational Approach to Fragment-Based Drug Design
Charles H. Reynolds, Ph.D., Senior Director, Discovery Technologies, Ansaris

Structure-Based Design Approaches to Optimize Binding Kinetics: Long-Residence Time Kinase Inhibitors
Peter C. Sennhenn, Ph.D., Director Medicinal Chemistry, Proteros Fragments GmbH

Next-Generation Shape Signatures: A Powerful Tool for Fragment-Based Drug Discovery
Randy Zauhar, Ph.D., Associate Professor, Chemistry & Biochemistry, University of the Sciences

View full details and register at: http://www.healthtech.com/sbd

Those that register before April 29 will receive the advanced registration discount.

Writers and editors are invited to attend.  To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (http://www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Bio-IT World: (http://www.bio-itworld.com)

Part of the Cambridge Healthtech Institute Media Group (http://www.chimediagroup.com), Bio-IT World magazine is a bimonthly publication that life science and IT/informatics professionals continuously reference to find information, news, and commentary on indispensable technologies and business strategies.  Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine. Cambridge Healthtech Media Group also hosts daily news and opinion at http://www.bio-itworld.com, a variety of e-newsletters, and a rich compendium of webinars and web symposia.  Cambridge Healthtech Media Group is based in Needham, Mass.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
http://www.healthtech.com/sbd